AGF Management Ltd. Boosts Stock Holdings in Chemed Corporation $CHE

AGF Management Ltd. boosted its position in Chemed Corporation (NYSE:CHEFree Report) by 50.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 7,529 shares of the company’s stock after purchasing an additional 2,535 shares during the quarter. AGF Management Ltd.’s holdings in Chemed were worth $3,371,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Vontobel Holding Ltd. boosted its holdings in shares of Chemed by 44.5% during the second quarter. Vontobel Holding Ltd. now owns 2,821 shares of the company’s stock valued at $1,374,000 after acquiring an additional 869 shares during the period. Sequoia Financial Advisors LLC bought a new position in Chemed in the 2nd quarter worth about $342,000. Vest Financial LLC increased its stake in shares of Chemed by 32.6% in the third quarter. Vest Financial LLC now owns 9,702 shares of the company’s stock valued at $4,344,000 after purchasing an additional 2,383 shares during the period. Fenimore Asset Management Inc raised its holdings in shares of Chemed by 28.3% during the third quarter. Fenimore Asset Management Inc now owns 37,240 shares of the company’s stock valued at $16,674,000 after buying an additional 8,222 shares during the last quarter. Finally, Fort Washington Investment Advisors Inc. OH boosted its position in shares of Chemed by 45.8% during the third quarter. Fort Washington Investment Advisors Inc. OH now owns 55,979 shares of the company’s stock worth $25,064,000 after buying an additional 17,587 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Monday, November 24th. The shares were sold at an average price of $437.55, for a total value of $875,100.00. Following the completion of the sale, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at $41,215,897.35. This represents a 2.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 3.29% of the company’s stock.

Chemed Stock Up 2.4%

CHE stock opened at $443.65 on Thursday. The company has a market capitalization of $6.28 billion, a price-to-earnings ratio of 23.46, a P/E/G ratio of 2.11 and a beta of 0.44. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60. The firm has a 50 day moving average of $436.40 and a two-hundred day moving average of $441.99.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were paid a dividend of $0.60 per share. The ex-dividend date was Monday, November 17th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s dividend payout ratio is presently 12.69%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Jefferies Financial Group lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Royal Bank Of Canada dropped their price target on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a research report on Monday, November 10th. Finally, Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Chemed presently has an average rating of “Moderate Buy” and a consensus price target of $555.50.

Read Our Latest Analysis on Chemed

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Recommended Stories

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.